Taxorest — EU research guide.
Taxorest is a Khavinson-series peptide bioregulator formulated for tracheal and bronchial epithelium, proposed to support respiratory tract cell regeneration in lung tissue aging models. It is typically discussed alongside Chonluten in pulmonary-focused research protocols.
What is Taxorest?
Taxorest is a Khavinson-series peptide bioregulator formulated for tracheal and bronchial epithelium, proposed to support respiratory tract cell regeneration in lung tissue aging models. It is typically discussed alongside Chonluten in pulmonary-focused research protocols.
What does the research show?
Published research is limited to small animal and Eastern European cohort studies on respiratory tissue markers. No independently replicated controlled human trials are publicly available as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Available only from a small number of specialist research vendors.
Molecular information
Pharmacokinetics
Taxorest is not yet in our price comparison
We expand EU supplier coverage every month.